FDA Responds to COVID-19

2020-02-18 |

The U.S. FDA is working with interagency and international partners, as well as medical product developers and manufacturers in efforts to combat 2019 Novel Coronavirus (COVID-19). The FDA’s responsibilities include monitoring the medical product supply chain to prevent shortages; monitoring overseas manufacture of products to ensure compliance with FDA requirements; inspection of imported consumer medical products; and expediting development and availability of medical products to diagnose, treat, and prevent the disease. Read the FDA statement.